Clinical Trial Update: Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and Ethinylestradiol [Phase 1]

View source ↗

Summary

Phase 1 study update evaluating potential drug interaction between dolutegravir and an oral contraceptive containing norgestimate and ethinylestradiol; the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Dolutegravir (dolutegravir)
• Oral contraceptive containing norgestimate and ethinylestradiol (norgestimate/ethinylestradiol)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED